ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

0A4J Astrazeneca Plc

0.00
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Astrazeneca Plc 0A4J London Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% -
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
1/02/202410:00UKREGAstraZeneca PLC Total Voting Rights
12/27/202302:00UKREGAstraZeneca PLC AstraZeneca acquires Gracell
12/22/202302:00UKREGAstraZeneca PLC Wainua (eplontersen) granted first US FDA..
12/14/202310:00UKREGAstraZeneca PLC Director/PDMR Shareholding
12/12/202302:05UKREGAstraZeneca PLC AstraZeneca to acquire Icosavax
12/01/202310:05UKREGAstraZeneca PLC Block listing Interim Review
12/01/202310:00UKREGAstraZeneca PLC Total Voting Rights
12/01/202302:00UKREGAstraZeneca PLC Discontinuation of two CRYSTALIZE evidence..
11/23/202310:00UKREGAstraZeneca PLC Director/PDMR Shareholding
11/17/202302:00UKREGAstraZeneca PLC Truqap approved in US for HR+ breast cancer
11/14/202302:05UKREGAstraZeneca PLC Update on PACIFIC-2 Phase III trial for..
11/09/202310:00UKREGAstraZeneca PLC Director Declaration
11/09/202302:10UKREGAstraZeneca PLC Imfinzi combination improves PFS in liver..
11/09/202302:05UKREGAstraZeneca PLC Agreement with Eccogene for clinical stage..
11/09/202302:00UKREGAstraZeneca PLC 9M and Q3 2023 results
11/01/202311:00UKREGAstraZeneca PLC Total Voting Rights
11/01/202303:00UKREGAstraZeneca PLC AstraZeneca cell & gene therapy deal w/..
10/03/202302:00UKREGAstraZeneca PLC AstraZeneca settles Nexium liability..
10/02/202310:00UKREGAstraZeneca PLC Total Voting Rights
9/22/202302:00UKREGAstraZeneca PLC Dato-DXd improved PFS in breast cancer
9/20/202302:00UKREGAstraZeneca PLC Alexion completes Pfizer gene therapy..
9/15/202310:00UKREGAstraZeneca PLC Enhertu recommended in EU for HER2-mutant..
9/11/202311:00UKREGAstraZeneca PLC Fasenra Phase III EGPA trial met primary..
9/06/202302:00UKREGAstraZeneca PLC Update on US review of Ultomiris for NMOSD
9/01/202310:00UKREGAstraZeneca PLC Total Voting Rights
8/01/202310:00UKREGAstraZeneca PLC Total Voting Rights
7/28/202302:05UKREGAstraZeneca PLC Alexion enters gene therapy agreement with..
7/28/202302:00UKREGAstraZeneca PLC Half-year Report
7/17/202313:10UKREGAstraZeneca PLC Beyfortus approved in US for infant RSV..
7/03/202310:00UKREGAstraZeneca PLC Total Voting Rights
7/03/202302:00UKREGAstraZeneca PLC Dato-DXd significantly improved PFS in lung..
6/09/202302:05UKREGAstraZeneca PLC nirsevimab recommended for infant RSV..
6/09/202302:00UKREGAstraZeneca PLC AstraZeneca agreement with Quell..
6/02/202312:00UKREGAstraZeneca PLC Imfinzi improved pCR in gastric and GEJ..
6/01/202310:05UKREGAstraZeneca PLC Block listing Interim Review
6/01/202310:00UKREGAstraZeneca PLC Total Voting Rights
6/01/202302:00UKREGAstraZeneca PLC Lynparza approved in US for BRCAm prostate..
5/26/202302:00UKREGAstraZeneca PLC Imfinzi + Lynparza prolonged PFS in..
5/22/202302:05UKREGAstraZeneca PLC Directorate Change
5/17/202302:00UKREGAstraZeneca PLC Tagrisso plus chemo improved PFS in lung..
5/09/202306:00UKREGAstraZeneca PLC Director/PDMR Shareholding
5/09/202302:00UKREGAstraZeneca PLC Farxiga extended in the US for heart failure

Your Recent History

Delayed Upgrade Clock